{"transactions":[{"id":758933,"issuer":{"id":6290,"kind":"organization","name":"Translational Development Acquisition Corp."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Warrants","published_at":"2026-05-29T20:05:16.000Z","date":"2026-05-27","kind":"purchase","planned":false,"acquired":true,"shares":53395,"price":0.7918,"value":42278.161,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 8 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $0.71 to $0.9997, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of warrants purchased at each separate price within the range set forth in this footnote. For reference, aggregate proceeds were $42,280.50 and the exact weighted average price was $0.7918438056."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each warrant becomes exercisable 30 days after completion of the Issuer's initial business combination, as described in the Issuer's filings with the Securities and Exchange Commission. The warrants expire five years after completion of the Issuer's initial business combination, or earlier upon redemption or liquidation, as described in the Issuer's filings with the Securities and Exchange Commission (the \"SEC\")"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each warrant becomes exercisable 30 days after completion of the Issuer's initial business combination, as described in the Issuer's filings with the Securities and Exchange Commission. The warrants expire five years after completion of the Issuer's initial business combination, or earlier upon redemption or liquidation, as described in the Issuer's filings with the Securities and Exchange Commission (the \"SEC\")"}],"balance_after":53395,"derivative":{"exercise_price":11.5,"underlying":"Class A ordinary shares","underlying_shares":53395},"source":{"system":"sec-edgar","filing":"0001104659-26-068236","document":"tm2616067-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1926599/000110465926068236/tm2616067-1_4seq1.xml","form_type":"4"}},{"id":767912,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T00:11:23.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":54933,"price":1.8999,"value":104367.2067,"ownership":{"direct":true},"balance_after":3364883,"source":{"system":"sec-edgar","filing":"0001104659-26-065311","document":"tm2615429-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926065311/tm2615429-1_4seq1.xml","form_type":"4"}},{"id":767911,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T00:11:23.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":18849,"price":1.8,"value":33928.2,"ownership":{"direct":true},"balance_after":3309950,"source":{"system":"sec-edgar","filing":"0001104659-26-065311","document":"tm2615429-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926065311/tm2615429-1_4seq1.xml","form_type":"4"}},{"id":767910,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-22T00:11:23.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":2562,"price":1.75,"value":4483.5,"ownership":{"direct":true},"balance_after":3291101,"source":{"system":"sec-edgar","filing":"0001104659-26-065311","document":"tm2615429-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926065311/tm2615429-1_4seq1.xml","form_type":"4"}},{"id":816275,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-03T21:06:28.000Z","date":"2026-04-02","kind":"purchase","planned":false,"acquired":true,"shares":713800,"price":2.1,"value":1498980.0,"ownership":{"direct":true},"balance_after":3288539,"source":{"system":"sec-edgar","filing":"0001104659-26-039675","document":"tm2611081-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926039675/tm2611081-1_4seq1.xml","form_type":"4"}},{"id":977563,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T01:05:14.000Z","date":"2025-12-08","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":4.24,"value":63600.0,"ownership":{"direct":true},"balance_after":2574739,"source":{"system":"sec-edgar","filing":"0001104659-25-119407","document":"tm2533031-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925119407/tm2533031-1_4seq1.xml","form_type":"4"}},{"id":977562,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T01:05:14.000Z","date":"2025-12-08","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":4.3398,"value":130194.0,"ownership":{"direct":true},"balance_after":2559739,"source":{"system":"sec-edgar","filing":"0001104659-25-119407","document":"tm2533031-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925119407/tm2533031-1_4seq1.xml","form_type":"4"}},{"id":988629,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:59:54.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":28096,"price":4.15,"value":116598.4,"ownership":{"direct":true},"balance_after":2529739,"source":{"system":"sec-edgar","filing":"0001104659-25-116084","document":"tm2532217-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925116084/tm2532217-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-11-24"}},{"id":988628,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:59:54.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":415,"price":4.14,"value":1718.1,"ownership":{"direct":true},"balance_after":2501643,"source":{"system":"sec-edgar","filing":"0001104659-25-116084","document":"tm2532217-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925116084/tm2532217-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-11-24"}},{"id":988627,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:59:54.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":9200,"price":3.85,"value":35420.0,"ownership":{"direct":true},"balance_after":2501228,"source":{"system":"sec-edgar","filing":"0001104659-25-116084","document":"tm2532217-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925116084/tm2532217-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-11-24"}},{"id":988626,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T23:59:54.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":1489,"price":4.13,"value":6149.57,"ownership":{"direct":true},"balance_after":2492028,"source":{"system":"sec-edgar","filing":"0001104659-25-116084","document":"tm2532217-1_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925116084/tm2532217-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2025-11-24"}},{"id":988623,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T17:26:46.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":28096,"price":4.15,"value":116598.4,"ownership":{"direct":true},"balance_after":2519739,"source":{"system":"sec-edgar","filing":"0001104659-25-115801","document":"tm2532176-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115801/tm2532176-1_4seq1.xml","form_type":"4"}},{"id":988622,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T17:26:46.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":415,"price":4.14,"value":1718.1,"ownership":{"direct":true},"balance_after":2491643,"source":{"system":"sec-edgar","filing":"0001104659-25-115801","document":"tm2532176-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115801/tm2532176-1_4seq1.xml","form_type":"4"}},{"id":988621,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T17:26:46.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":9200,"price":3.85,"value":35420.0,"ownership":{"direct":true},"balance_after":2491228,"source":{"system":"sec-edgar","filing":"0001104659-25-115801","document":"tm2532176-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115801/tm2532176-1_4seq1.xml","form_type":"4"}},{"id":988620,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-25T17:26:46.000Z","date":"2025-11-24","kind":"purchase","planned":false,"acquired":true,"shares":1489,"price":4.13,"value":6149.57,"ownership":{"direct":true},"balance_after":2482028,"source":{"system":"sec-edgar","filing":"0001104659-25-115801","document":"tm2532176-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115801/tm2532176-1_4seq1.xml","form_type":"4"}},{"id":991251,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T00:57:45.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.5,"value":35000.0,"ownership":{"direct":true},"balance_after":2490539,"source":{"system":"sec-edgar","filing":"0001104659-25-115090","document":"tm2531989-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115090/tm2531989-1_4seq1.xml","form_type":"4"}},{"id":991250,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-22T00:57:45.000Z","date":"2025-11-21","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.49,"value":34900.0,"ownership":{"direct":true},"balance_after":2480539,"source":{"system":"sec-edgar","filing":"0001104659-25-115090","document":"tm2531989-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925115090/tm2531989-1_4seq1.xml","form_type":"4"}},{"id":995640,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T12:44:02.000Z","date":"2025-11-14","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":2.11,"value":31650.0,"ownership":{"direct":true},"balance_after":2470539,"source":{"system":"sec-edgar","filing":"0001104659-25-113459","document":"tm2531527-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925113459/tm2531527-1_4seq1.xml","form_type":"4"}},{"id":1001950,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-12T14:18:23.000Z","date":"2025-10-28","kind":"purchase","planned":false,"acquired":true,"shares":975610,"price":2.05,"value":2000000.5,"ownership":{"direct":true},"balance_after":2455539,"source":{"system":"sec-edgar","filing":"0001104659-25-109905","document":"tm2527472-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925109905/tm2527472-2_4seq1.xml","form_type":"4"}},{"id":1049506,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T20:41:47.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":2.3,"value":11500.0,"ownership":{"direct":true},"balance_after":1479929,"source":{"system":"sec-edgar","filing":"0001104659-25-087077","document":"tm2525175-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925087077/tm2525175-1_4seq1.xml","form_type":"4"}},{"id":1049505,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T20:41:47.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":2.29,"value":11450.0,"ownership":{"direct":true},"balance_after":1474929,"source":{"system":"sec-edgar","filing":"0001104659-25-087077","document":"tm2525175-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925087077/tm2525175-1_4seq1.xml","form_type":"4"}},{"id":1049504,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-03T20:41:47.000Z","date":"2025-08-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":2.28,"value":11400.0,"ownership":{"direct":true},"balance_after":1469929,"source":{"system":"sec-edgar","filing":"0001104659-25-087077","document":"tm2525175-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925087077/tm2525175-1_4seq1.xml","form_type":"4"}},{"id":1060203,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T21:20:14.000Z","date":"2025-08-19","kind":"grant","planned":false,"acquired":true,"shares":1100,"price":2.57,"value":2827.0,"ownership":{"direct":true},"balance_after":1464929,"source":{"system":"sec-edgar","filing":"0001104659-25-080981","document":"tm2523925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925080981/tm2523925-1_4seq1.xml","form_type":"4"}},{"id":1060202,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T21:20:14.000Z","date":"2025-08-19","kind":"grant","planned":false,"acquired":true,"shares":5545,"price":2.58,"value":14306.1,"ownership":{"direct":true},"balance_after":1463829,"source":{"system":"sec-edgar","filing":"0001104659-25-080981","document":"tm2523925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925080981/tm2523925-1_4seq1.xml","form_type":"4"}},{"id":1060201,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T21:20:14.000Z","date":"2025-08-19","kind":"grant","planned":false,"acquired":true,"shares":5283,"price":2.59,"value":13682.97,"ownership":{"direct":true},"balance_after":1458284,"source":{"system":"sec-edgar","filing":"0001104659-25-080981","document":"tm2523925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925080981/tm2523925-1_4seq1.xml","form_type":"4"}},{"id":1060200,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-20T21:20:14.000Z","date":"2025-08-19","kind":"grant","planned":false,"acquired":true,"shares":6717,"price":2.6,"value":17464.2,"ownership":{"direct":true},"balance_after":1453001,"source":{"system":"sec-edgar","filing":"0001104659-25-080981","document":"tm2523925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925080981/tm2523925-1_4seq1.xml","form_type":"4"}},{"id":1109719,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:28:52.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":1,"price":2.83,"value":2.83,"ownership":{"direct":true},"balance_after":1446284,"source":{"system":"sec-edgar","filing":"0001104659-25-059897","document":"tm2518124-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925059897/tm2518124-1_4seq1.xml","form_type":"4"}},{"id":1109718,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:28:52.000Z","date":"2025-06-13","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":2.8,"value":70000.0,"ownership":{"direct":true},"balance_after":1446283,"source":{"system":"sec-edgar","filing":"0001104659-25-059897","document":"tm2518124-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925059897/tm2518124-1_4seq1.xml","form_type":"4"}},{"id":1127586,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T20:35:53.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":2.43,"value":12150.0,"ownership":{"direct":true},"balance_after":1421283,"source":{"system":"sec-edgar","filing":"0001104659-25-055487","document":"tm2516868-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465925055487/tm2516868-1_4seq1.xml","form_type":"4"}},{"id":1459840,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-07-03T21:16:18.000Z","date":"2023-11-17","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest immediately upon grant date."}],"balance_after":29600,"derivative":{"exercise_price":6.07,"expiration_date":"2033-11-17","underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001104659-24-077833","document":"tm2417696-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465924077833/tm2417696-2_4seq1.xml","form_type":"4"}},{"id":1731160,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-22T21:24:21.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":163880,"price":6.1,"value":999668.0,"ownership":{"direct":false,"nature":"The 2018 Jane and Michael Hoffman Descendants Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares."}],"balance_after":223357,"source":{"system":"sec-edgar","filing":"0001104659-23-120764","document":"tm2331305-9_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120764/tm2331305-9_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-11-21"}},{"id":1732548,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T19:32:26.000Z","date":"2023-11-20","kind":"grant","planned":false,"acquired":true,"shares":164745,"price":6.07,"value":1000002.15,"ownership":{"direct":false,"nature":"The 2018 Jane and Michael Hoffman Descendants Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares."}],"balance_after":224222,"source":{"system":"sec-edgar","filing":"0001104659-23-120304","document":"tm2331305-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923120304/tm2331305-5_4seq1.xml","form_type":"4"}},{"id":1921740,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-04-12T01:06:18.000Z","date":"2023-04-07","kind":"grant","planned":false,"acquired":true,"shares":59477,"price":12.61,"value":750004.97,"ownership":{"direct":false,"nature":"The 2018 Jane and Michael Hoffman Descendants Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares."}],"balance_after":59477,"source":{"system":"sec-edgar","filing":"0001104659-23-044204","document":"tm2312464-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923044204/tm2312464-3_4seq1.xml","form_type":"4"}},{"id":2049669,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-20T22:38:36.000Z","date":"2023-01-18","kind":"grant","acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025."}],"balance_after":6820,"derivative":{"exercise_price":13.17,"expiration_date":"2033-01-18","underlying":"Common Stock","underlying_shares":6820},"source":{"system":"sec-edgar","filing":"0001104659-23-005476","document":"tm234043-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465923005476/tm234043-2_4seq1.xml","form_type":"4"}},{"id":2443820,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"exercise","acquired":false,"shares":7142,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.25,"exercise_date":"2018-04-06","expiration_date":"2028-04-06","underlying":"Common Stock","underlying_shares":7142},"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443819,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.39,"exercise_date":"2020-07-01","expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443818,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option shall vest in eight consecutive quarterly installments of 1,125 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024."}],"balance_after":9000,"derivative":{"exercise_price":19.78,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443817,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"tax_withholding","acquired":false,"shares":90,"price":19.78,"value":1780.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects 90 shares withheld by issuer at the market price of $19.78 per share less an exercise price of $0.25 per share to fund the cashless exercise of 7,142 options."}],"balance_after":1416283,"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443816,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"exercise","acquired":true,"shares":7142,"price":0.25,"value":1785.5,"ownership":{"direct":true},"balance_after":1416373,"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443815,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"tax_withholding","acquired":false,"shares":6658,"price":19.78,"value":131695.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects 6,658 shares withheld by issuer at the market price of $19.78 per share less an exercise price of $4.39 per share to fund the cashless exercise of 30,000 options."}],"balance_after":1409231,"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2443814,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T00:41:42.000Z","date":"2022-01-04","kind":"exercise","acquired":true,"shares":30000,"price":4.39,"value":131700.0,"ownership":{"direct":true},"balance_after":1415889,"source":{"system":"sec-edgar","filing":"0001104659-22-001638","document":"tm221949-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465922001638/tm221949-2_4seq1.xml","form_type":"4"}},{"id":2637009,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-09T22:26:25.000Z","date":"2021-07-07","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date."}],"balance_after":4500,"derivative":{"exercise_price":102.85,"expiration_date":"2031-07-07","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001104659-21-090742","document":"tm2121908-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465921090742/tm2121908-2_4seq1.xml","form_type":"4"}},{"id":3043909,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-31T20:42:48.000Z","date":"2020-08-27","kind":"sale","acquired":false,"shares":1876,"price":0.2719,"value":510.0844,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-20-009437","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020009437/edgar.xml","form_type":"4"}},{"id":3043908,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-31T20:42:48.000Z","date":"2020-08-27","kind":"sale","acquired":false,"shares":182492,"price":0.2719,"value":49619.5748,"ownership":{"direct":false,"nature":"By the Michael and Jane Hoffman 2013 Descendants Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust."}],"balance_after":21919,"source":{"system":"sec-edgar","filing":"0001179110-20-009437","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020009437/edgar.xml","form_type":"4"}},{"id":3085067,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Appreciation Right","published_at":"2020-07-10T21:29:11.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock appreciation rights vest 100% on the first anniversary of the grant date."}],"balance_after":125000,"derivative":{"exercise_price":0.56,"exercise_date":"2021-07-09","expiration_date":"2030-07-09","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001179110-20-008193","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911020008193/edgar.xml","form_type":"4"}},{"id":3088737,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-06T20:30:25.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":4.39,"exercise_date":"2020-07-01","expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-20-081235","document":"a4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920081235/a4a.xml","form_type":"4/A","original_submission_date":"2020-02-05"}},{"id":3288609,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2020-02-05T11:05:41.000Z","date":"2020-01-31","kind":"exercise","acquired":false,"shares":55884,"price":4.8,"value":268243.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The convertible notes have a maturity date of December 31, 2023. The Convertible Notes automatically converted into common stock of Annovis upon the closing of the IPO at a conversion rate equal to the principal amount of the note, plus accrued and unpaid interest, divided by $4.80 (80% of the IPO price)."},{"field":"shares","element":"transactionShares","label":"F4","text":"The convertible notes have a maturity date of December 31, 2023. The Convertible Notes automatically converted into common stock of Annovis upon the closing of the IPO at a conversion rate equal to the principal amount of the note, plus accrued and unpaid interest, divided by $4.80 (80% of the IPO price)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The convertible notes have a maturity date of December 31, 2023. The Convertible Notes automatically converted into common stock of Annovis upon the closing of the IPO at a conversion rate equal to the principal amount of the note, plus accrued and unpaid interest, divided by $4.80 (80% of the IPO price)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The convertible notes have a maturity date of December 31, 2023. The Convertible Notes automatically converted into common stock of Annovis upon the closing of the IPO at a conversion rate equal to the principal amount of the note, plus accrued and unpaid interest, divided by $4.80 (80% of the IPO price)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":55884},"source":{"system":"sec-edgar","filing":"0001104659-20-010943","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010943/a4.xml","form_type":"4"}},{"id":3288608,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-02-05T11:05:41.000Z","date":"2020-01-31","kind":"exercise","acquired":false,"shares":1593118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1137942},"source":{"system":"sec-edgar","filing":"0001104659-20-010943","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010943/a4.xml","form_type":"4"}},{"id":3288607,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2020-02-05T11:05:41.000Z","date":"2020-01-31","kind":"exercise","acquired":false,"shares":222222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":158730},"source":{"system":"sec-edgar","filing":"0001104659-20-010943","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010943/a4.xml","form_type":"4"}},{"id":3288606,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T11:05:41.000Z","date":"2020-01-31","kind":"exercise","acquired":true,"shares":55884,"price":4.8,"value":268243.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The convertible notes have a maturity date of December 31, 2023. The Convertible Notes automatically converted into common stock of Annovis upon the closing of the IPO at a conversion rate equal to the principal amount of the note, plus accrued and unpaid interest, divided by $4.80 (80% of the IPO price)."}],"balance_after":1400175,"source":{"system":"sec-edgar","filing":"0001104659-20-010943","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010943/a4.xml","form_type":"4"}},{"id":3288605,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T11:05:41.000Z","date":"2020-01-31","kind":"exercise","acquired":true,"shares":1137942,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series A Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":1344291,"source":{"system":"sec-edgar","filing":"0001104659-20-010943","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010943/a4.xml","form_type":"4"}},{"id":3288604,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T11:05:41.000Z","date":"2020-01-31","kind":"exercise","acquired":true,"shares":158730,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series A-1 Preferred Stock automatically converted into common stock of Annovis upon the closing of the IPO at a conversion ratio of one for 0.7143."}],"balance_after":206349,"source":{"system":"sec-edgar","filing":"0001104659-20-010943","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010943/a4.xml","form_type":"4"}},{"id":3288603,"issuer":{"id":7001,"kind":"organization","name":"Annovis Bio, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-02-05T11:05:41.000Z","date":"2020-01-31","kind":"purchase","acquired":true,"shares":33333,"price":6,"value":199998.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person acquired these shares in the initial public offering (\"IPO\") of Annovis Bio, Inc. (\"Annovis\")."}],"balance_after":47619,"source":{"system":"sec-edgar","filing":"0001104659-20-010943","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465920010943/a4.xml","form_type":"4"}},{"id":3454399,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2019-07-29T21:26:17.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":5833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 100% on the first anniversary of the grant date."}],"balance_after":5833,"derivative":{"exercise_price":3.39,"exercise_date":"2020-07-26","expiration_date":"2029-07-26","underlying":"Common Stock","underlying_shares":5833},"source":{"system":"sec-edgar","filing":"0001179110-19-008869","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911019008869/edgar.xml","form_type":"4"}},{"id":3830742,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-29T21:22:18.000Z","date":"2018-08-29","kind":"sale","acquired":false,"shares":29999.262,"price":0.4507,"value":13520.6673834,"ownership":{"direct":false,"nature":"By the Michael and Jane Hoffman 2018 Descendants Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 19,951 options to purchase shares of Common Stock of the Issuer, which are immediately exercisable or will be exercisable within 60 days of the date hereof; (ii) 5,700,836.738 shares of Common Stock held by the Michael and Jane Hoffman 2018 Descendants Trust, of which Mr. Hoffman is donor (which includes 2,211,765 shares of Common Stock issuable upon the exercise of warrants for 55,294.125 shares of Series B Preferred Stock that convert into shares of Common Stock and 396,633 shares of Common Stock issuable upon the exercise of warrants, all of which are immediately exercisable or exercisable within 60 days hereof); and (iii) 8,453 shares of Common Stock held by the Michael and Jane Hoffman 2013 Descendants Trust (Non-GST Exempt Trust), of which Mr. Hoffman is donor."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held for the benefit of the reporting person's descendants.  The reporting person's spouse is a trustee of the trust. The reporting person is a general agent of the trust."}],"balance_after":5731116.738,"source":{"system":"sec-edgar","filing":"0001104659-18-054173","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000110465918054173/a4.xml","form_type":"4"}},{"id":3830741,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-29T21:22:18.000Z","date":"2018-08-28","kind":"sale","acquired":false,"shares":30000,"price":0.4569,"value":13707.0,"ownership":{"direct":false,"nature":"By the Michael and Jane Hoffman 2018 Descendants Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 19,951 options to purchase shares of Common Stock of the Issuer, which are immediately exercisable or will be exercisable within 60 days of the date hereof; (ii) 5,700,836.738 shares of Common Stock held by the Michael and Jane Hoffman 2018 Descendants Trust, of which Mr. Hoffman is donor (which includes 2,211,765 shares of Common Stock issuable upon the exercise of warrants for 55,294.125 shares of Series B Preferred Stock that convert into shares of Common Stock and 396,633 shares of Common Stock issuable upon the exercise of warrants, all of which are immediately exercisable or exercisable within 60 days hereof); and (iii) 8,453 shares of Common Stock held by the Michael and Jane Hoffman 2013 Descendants Trust (Non-GST Exempt Trust), of which Mr. Hoffman is donor."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held for the benefit of the reporting person's descendants.  The reporting person's spouse is a trustee of the trust. The reporting person is a general agent of the trust."}],"balance_after":5761116,"source":{"system":"sec-edgar","filing":"0001104659-18-054173","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000110465918054173/a4.xml","form_type":"4"}},{"id":3830740,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-29T21:22:18.000Z","date":"2018-08-28","kind":"sale","acquired":false,"shares":20000,"price":0.4445,"value":8890.0,"ownership":{"direct":false,"nature":"By the Michael and Jane Hoffman 2018 Descendants Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 19,951 options to purchase shares of Common Stock of the Issuer, which are immediately exercisable or will be exercisable within 60 days of the date hereof; (ii) 5,700,836.738 shares of Common Stock held by the Michael and Jane Hoffman 2018 Descendants Trust, of which Mr. Hoffman is donor (which includes 2,211,765 shares of Common Stock issuable upon the exercise of warrants for 55,294.125 shares of Series B Preferred Stock that convert into shares of Common Stock and 396,633 shares of Common Stock issuable upon the exercise of warrants, all of which are immediately exercisable or exercisable within 60 days hereof); and (iii) 8,453 shares of Common Stock held by the Michael and Jane Hoffman 2013 Descendants Trust (Non-GST Exempt Trust), of which Mr. Hoffman is donor."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held for the benefit of the reporting person's descendants.  The reporting person's spouse is a trustee of the trust. The reporting person is a general agent of the trust."}],"balance_after":5791116,"source":{"system":"sec-edgar","filing":"0001104659-18-054173","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000110465918054173/a4.xml","form_type":"4"}},{"id":3830739,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-29T21:22:18.000Z","date":"2018-08-27","kind":"sale","acquired":false,"shares":20000,"price":0.4535,"value":9070.0,"ownership":{"direct":false,"nature":"By the Michael and Jane Hoffman 2018 Descendants Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 19,951 options to purchase shares of Common Stock of the Issuer, which are immediately exercisable or will be exercisable within 60 days of the date hereof; (ii) 5,700,836.738 shares of Common Stock held by the Michael and Jane Hoffman 2018 Descendants Trust, of which Mr. Hoffman is donor (which includes 2,211,765 shares of Common Stock issuable upon the exercise of warrants for 55,294.125 shares of Series B Preferred Stock that convert into shares of Common Stock and 396,633 shares of Common Stock issuable upon the exercise of warrants, all of which are immediately exercisable or exercisable within 60 days hereof); and (iii) 8,453 shares of Common Stock held by the Michael and Jane Hoffman 2013 Descendants Trust (Non-GST Exempt Trust), of which Mr. Hoffman is donor."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held for the benefit of the reporting person's descendants.  The reporting person's spouse is a trustee of the trust. The reporting person is a general agent of the trust."}],"balance_after":5811116,"source":{"system":"sec-edgar","filing":"0001104659-18-054173","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000110465918054173/a4.xml","form_type":"4"}},{"id":3859175,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2018-07-30T21:34:38.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 100% on the first anniversary of the grant date."}],"balance_after":87500,"derivative":{"exercise_price":0.46,"exercise_date":"2019-07-26","expiration_date":"2028-07-26","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0001179110-18-010016","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911018010016/edgar.xml","form_type":"4"}},{"id":3952251,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2018-05-01T22:34:09.000Z","date":"2018-04-27","kind":"purchase","acquired":true,"shares":2211765,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By the Michael and Jane Hoffman 2013 Descendants Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock and warrants reported on this Form 4 were acquired in a public offering, by Onconova Therapeutics, Inc. (the Company), of units which included one share of common stock and one warrant. The public offering price for each unit was $0.425. The public offering, during which the Company also sold other securities, was pursuant to the Company's effective registration statement on Form S-1 (File No. 333-224315)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrants are exercisable immediately at an exercise price of $0.425 per 0.025 share of Series B Convertible Preferred Stock and will expire on the 18-month anniversary of the date on which the Company publicly announces through the filing of a Current Report on Form 8-K that a Charter Amendment, increasing the number of available common shares, has been filed with the Secretary of State of the State of Delaware."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust."}],"balance_after":2211765,"derivative":{"exercise_price":0.425,"exercise_date":"2018-04-27","underlying":"Series B Convertible Preferred Stock","underlying_shares":55294.13},"source":{"system":"sec-edgar","filing":"0001179110-18-006018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911018006018/edgar.xml","form_type":"4"}},{"id":3952250,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-01T22:34:09.000Z","date":"2018-04-27","kind":"purchase","acquired":true,"shares":2211765,"ownership":{"direct":false,"nature":"By the Michael and Jane Hoffman 2013 Descendants Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The common stock and warrants reported on this Form 4 were acquired in a public offering, by Onconova Therapeutics, Inc. (the Company), of units which included one share of common stock and one warrant. The public offering price for each unit was $0.425. The public offering, during which the Company also sold other securities, was pursuant to the Company's effective registration statement on Form S-1 (File No. 333-224315)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust."}],"balance_after":3192438,"source":{"system":"sec-edgar","filing":"0001179110-18-006018","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911018006018/edgar.xml","form_type":"4"}},{"id":4284002,"issuer":{"id":8032,"kind":"organization","name":"Traws Pharma, Inc."},"owners":[{"id":43214,"kind":"person","name":"Hoffman Michael B","position":1,"cik":"0001290208","reported_name":"Hoffman Michael B","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to purchase)","published_at":"2017-06-13T21:08:09.000Z","date":"2017-06-12","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest over one year from the grant date in 12 equal monthly installments."}],"balance_after":2000,"derivative":{"exercise_price":1.94,"expiration_date":"2027-06-12","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001179110-17-008999","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130598/000117911017008999/edgar.xml","form_type":"4"}}]}